首页 | 本学科首页   官方微博 | 高级检索  
检索        

Radiotherapy combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma - a prospective clinical trial
作者姓名:Ling  Cai  Mengzhong  Liu  Xiushen  Wang  Mofa  Gu  Hui  Liu  Qun  Li  Nianji  Cui  Guohui  Li  Jinqing  Li
作者单位:[1]Department of Radiation Oncology and Medical Physics, The Cancer Center of Sun Yat-Sen University, Guangzhou 510060, China [2]Deparment of Hepatobiliary Tumor, The Cancer Center of Sun Yat-Sen University, Guangzhou 510060, China
摘    要:Objective: This study evaluated the therapeutic effect of external beam radiotherapy (RT) combined with transcatheter arterial chemoembolization (TACE) on the patients with unresectable hepatocellular carcinoma (HCC). Methods: From June 1994 to April 2002, 114 patients with unresectable HCC were nonrandomized prospectively stepped into our study. All patients received TACE as initial therapy, except 54 also received combination therapy with external beam therapy. Survival failure patterns were analyzed and compared between the two groups. Results: Overall survival rates in the patients in the radiotherapy group were 65%, 47%, 38% at 1,2, 3 years, respectively, improved over the non-radiotherapy group rates of 54%, 36.5%, 18% at 1, 2, 3 years, respectively. There was significant difference between two groups (P 〈 0.05). The survival rates correlated with tumor size, number of tumors, and portal vein embolus. Conclusion: TACE combined with RT is a more effective treatment than TACE alone in patients with unresectable HCC.

关 键 词:外照射治疗  肝动脉栓塞  手术切除  原发性肝癌
文章编号:10.1007/s10330-007-0144-y
收稿时间:2007-08-20
修稿时间:2007-09-30

Radiotherapy combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma — a prospective clinical trial
Ling Cai Mengzhong Liu Xiushen Wang Mofa Gu Hui Liu Qun Li Nianji Cui Guohui Li Jinqing Li.Radiotherapy combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma - a prospective clinical trial[J].The Chinese-German Journal of Clinical Oncology,2008,7(2):64-68.
Authors:Ling Cai  Mengzhong Liu  Xiushen Wang  Mofa Gu  Hui Liu  Qun Li  Nianji Cui  Guohui Li  Jinqing Li
Institution:(1) Department of Radiation Oncology and Medical Physics, The Cancer Center of Sun Yat-Sen University, Guangzhou, 510060, China;(2) Deparment of Hepatobiliary Tumor, The Cancer Center of Sun Yat-Sen University, Guangzhou, 510060, China
Abstract:Objective This study evaluated the therapeutic effect of external beam radiotherapy (RT) combined with transcatheter arterial chemoembolization (TACE) on the patients with unresectable hepatocellular carcinoma (HCC). Methods From June 1994 to April 2002, 114 patients with unresectable HCC were nonrandomized prospectively stepped into our study. All patients received TACE as initial therapy, except 54 also received combination therapy with external beam therapy. Survival failure patterns were analyzed and compared between the two groups. Results Overall survival rates in the patients in the radiotherapy group were 65%, 47%, 38% at 1, 2, 3 years, respectively, improved over the non-radiotherapy group rates of 54%, 36.5%, 18% at 1, 2, 3 years, respectively. There was significant difference between two groups (P < 0.05). The survival rates correlated with tumor size, number of tumors, and portal vein embolus. Conclusion TACE combined with RT is a more effective treatment than TACE alone in patients with unresectable HCC.
Keywords:radiotherapy  transcatheter arterial chemoembolization  hepatocellular carcinoma
本文献已被 维普 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号